NANTONG,
According to the Chinese government's healthcare reform plan, 90 percent
of
"While Sinobiopharma is primarily focused on the development, production
and distribution of "me-too/me-better" branded new or generic drugs with high
margins, the inclusion of 23 generic drugs for which the Company owns
production rights on the National Essential Drugs List, will enable us to
increase both sales and margins," said Dr.
About Sinobiopharma
Sinobiopharma, Inc. is a fully integrated and highly innovative specialty
biopharmaceutical company engaged in the research and development, manufacture
and marketing of biopharmaceutical products in
FORWARD LOOKING STATEMENTS
This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiopharma, Inc. does not undertake any obligation to update any forward looking statement, except as required under applicable law.
SOURCE Sinobiopharma, Inc.